Kohlberg & Company, a private equity firm, agreed to acquire a majority stake in Trinity Life Sciences, a life sciences commercialization solutions provider. Financial terms were not disclosed. “We are thrilled to partner with Kohlberg through our next chapter of growth as we continue to empower the life sciences industry to deliver life-changing therapies to patients. Kohlberg will help us strategically grow. You will see a greater emphasis on optimizing our global reach, introducing technology that our clients can easily leverage into their own current systems, and a continued focus on actionable data that fuels all our innovative products and services," David Fitzhenry, Trinity Life Sciences CEO.